7月11日，美好医疗今日收盘18.72元，上涨3.83%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到29.78倍，创28天以来新低，总市值106.49亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均52.06倍，行业中值37.22倍，美好医疗排 名第66位。 股东方面，截至2025年6月30日，美好医疗股东户数12487户，较上次增加119户，户均持股市值35.28万 元，户均持股数量2.76万股。 最新一期业绩显示，2025年一季报，公司实现营业收入2.96亿元，同比5.05%；净利润5187.50万元，同 比-10.62%，销售毛利率39.28%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13美好医疗29.7829.273.02106.49亿行业平均 52.0649.724.58107.83亿行业中值37.2238.112.4752.18亿1九安医疗10.3010.410.81173.78亿2英科医疗 10.8811.730.97171.88亿3新华医疗14.4413.391.1892.58亿4振德医疗15.4114.530.9855.95亿5奥美医疗 15. ...

7月4日，美好医疗今日收盘18.05元，上涨1.69%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到28.71倍，总市值102.68亿元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13美好医疗28.7128.232.92102.68亿行业平均 51.0548.784.55107.12亿行业中值36.6236.522.5051.67亿1九安医疗10.2610.380.81173.21亿2英科医疗 10.4711.290.93165.45亿3新华医疗14.4313.381.1892.52亿4奥美医疗15.3215.011.5755.35亿5山东药玻 15.3915.431.77145.53亿6振德医疗15.4714.580.9856.17亿7康德莱15.7315.741.3033.89亿8维力医疗 16.4917.141.9337.60亿9九强生物16.4915.332.0281.66亿10奥泰生物16.6117.511.3452.96亿11安杰思 17.6117.812.1352.26亿12安图生物18.8317.982.42214.74亿 来源：金融界 从行业市盈率排名来看，公司 ...

Company Overview - Meihao Medical closed at 17.25 yuan on June 26, down 1.09%, with a rolling PE ratio of 27.44 times and a total market capitalization of 9.813 billion yuan [1] - The company operates in the medical device industry, which has an average PE ratio of 49.45 times and a median of 35.92 times, placing Meihao Medical at the 63rd position in the industry ranking [1] Shareholding Structure - As of the first quarter of 2025, 30 institutions held shares in Meihao Medical, including 24 funds, 4 others, and 2 insurance companies, with a total shareholding of 42.1394 million shares valued at 1.23 billion yuan [1] Business Operations - Meihao Medical specializes in the design, development, manufacturing, and sales of precision components and products for medical devices, including home ventilator components, cochlear implant components, and other medical product components [1] - The company is recognized as a national high-tech enterprise and a national intellectual property advantage enterprise, as well as a champion in a specific manufacturing sector in Guangdong Province [1] Financial Performance - In the first quarter of 2025, Meihao Medical reported revenue of 296 million yuan, a year-on-year increase of 5.05%, and a net profit of 51.875 million yuan, reflecting a year-on-year decrease of 10.62%, with a gross profit margin of 39.28% [1]

6月9日，美好医疗今日收盘17.48元，上涨2.52%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到27.81倍，总市值99.44亿元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)59美好医疗27.8127.342.8299.44亿行业平均 50.6449.074.68109.10亿行业中值37.0537.632.5050.67亿1天益医疗-1817.92-3113.901.9423.17亿2澳华内 镜-726.69364.475.8276.58亿3诺唯赞-431.93-510.862.3792.43亿4爱朋医疗-431.66327.945.2035.42亿5博晖 创新-337.40535.413.6049.50亿6硕世生物-147.79-2159.571.3243.23亿7奥精医疗-142.33-208.621.8826.42亿 8睿昂基因-105.65-86.741.5013.67亿9康泰医学-87.85-74.223.1357.82亿10中红医疗-74.13-59.130.9451.52亿 11热景生物-67.89-78.225.01149.40亿 来源：金融界 股东方面，截 ...

最新一期业绩显示，2025年一季报，公司实现营业收入2.96亿元，同比5.05%；净利润5187.50万元，同 比-10.62%，销售毛利率39.28%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)62美好医疗27.4627.002.7998.21亿行业平均 48.7146.924.57105.44亿行业中值35.3737.132.4047.42亿1天益医疗-1727.26-2958.601.8422.01亿2澳华内 镜-604.66303.274.8463.72亿3诺唯赞-406.65-480.962.2387.02亿4爱朋医疗-349.63265.624.2128.69亿5博晖 创新-321.82510.673.4347.22亿6硕世生物-133.72-1954.031.2039.11亿7奥精医疗-130.00-190.551.7124.13亿 8睿昂基因-100.64-82.631.4313.03亿9康泰医学-85.59-72.313.0556.33亿10中红医疗-70.71-56.400.8949.14亿 11华大智造-56.60-50.233.90301.77亿 来源：金融界 5月22日 ...

5月12日，美好医疗今日收盘26.16元，上涨3.24%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到29.75倍，总市值106.38亿元。 最新一期业绩显示，2025年一季报，公司实现营业收入2.96亿元，同比5.05%；净利润5187.50万元，同 比-10.62%，销售毛利率39.28%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)68美好医疗29.7529.243.02106.38亿行业平均 49.8445.684.61105.51亿行业中值36.5938.052.4346.93亿1天益医疗-1742.06-2983.951.8622.20亿2澳华内 镜-602.36302.124.8363.48亿3诺唯赞-409.62-484.482.2587.66亿4爱朋医疗-362.84275.654.3729.77亿5博晖 创新-324.04514.213.4647.54亿6硕世生物-131.86-1926.851.1838.57亿7奥精医疗-125.28-183.621.6523.25亿 8睿昂基因-99.99-82.091.4212.94亿9康泰医学-84.67-71.543. ...

4月25日，美好医疗今日收盘24.47元，下跌7.97%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到27.83倍，总市值99.51亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均45.11倍，行业中值33.83倍，美好医疗排 名第68位。 资金流向方面，4月25日，美好医疗主力资金净流入1273.24万元，近5日总体呈流出状态，5日共流出 3382.90万元。 深圳市美好创亿医疗科技股份有限公司的主营业务是医疗器械精密组件及产品的设计开发、制造和销 售。公司的主要产品是家用呼吸机组件、人工植入耳蜗组件、其他医疗产品组件、精密模具及自动化设 备、家用及消费电子组件。公司是国家级高新技术企业，国家知识产权优势企业，广东省制造业单项冠 军。 最新一期业绩显示，2025年一季报，公司实现营业收入2.96亿元，同比5.05%；净利润5187.50万元，同 比-10.62%，销售毛利率39.28%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)68美好医疗27.8327.352.8399.51亿行业平均 45.1147.464.57101.63亿行业中值33.8331.852.2 ...